Spanish Health Care Ticket Opposed

6 February 1995

Spanish Health Minister Angeles Amador has said that she is totally opposed to a health assistance ticket. She told the Spanish financial daily, Cinco Dias, that she is satisfied with the agreements reached regarding health care financing, including that reached with the Spanish drug industry.

Ms Amador said that if the ticket is only to be a symbolic way of raising finances it is not worth the effort, because it does not have any financial significance and would be expensive from an administrative point of view. If it is not symbolic, she said, it is profoundly unreasonable. It will take from the people who most need assistance, particularly with regard to prevention.

The Health Minister called for private health insurance companies to incorporate more clarity into the information they provide so that consumers can subscribe to a plan knowing what they are paying and what they are getting.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight